ProQinase GmbH

ProQinase GmbH was founded in 2001 as a 100% subsidiary of the Tumor Biology Center Freiburg, which is one of the largest privately owned hospitals of this type in Europe. ProQinase has been growing steadily over the past years. It has meanwhile a personal of 33 and offers its Integrated Protein Kinase Technology Platform, which is uniquely designed for drug development targeting protein kinases in cancer. It features the complete preclinical drug discovery cycle and even, due to ProQinase’s affiliation, rapid access to clinical trials in the private cancer hospital.